Literature DB >> 20229162

[STEMI guidelines 2008--Do they influence today's myocardial infarction treatment strategies in rural areas?].

Alois Suessenbacher1, Maria M Wanitschek, Jakob Doerler, Otmar Pachinger, Hannes F Alber.   

Abstract

2008 new guidelines for the management of patients with ST-elevation myocardial infarction were published by the European Society of Cardiology. For daily clinical practice, changes in recommendations concerning the preferred revascularization therapy according to different time delays are of great interest. This review focuses on possible implications of these new guidelines on the choice of reperfusion strategies in rural areas.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20229162     DOI： 10.1007/s10354-009-0739-8

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN： 0043-5341


  43 in total

1.  Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: is timing (almost) everything?

Authors:  Brahmajee K Nallamothu; Eric R Bates
Journal:  Am J Cardiol       Date:  2003-10-01       Impact factor: 2.778

2.  Universal definition of myocardial infarction.

Authors:  Kristian Thygesen; Joseph S Alpert; Harvey D White
Journal:  Eur Heart J       Date:  2007-10       Impact factor: 29.983

3.  Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial.

Authors: 
Journal:  Lancet       Date:  2006-02-18       Impact factor: 79.321

4.  Long-term cost effectiveness of early and sustained dual oral antiplatelet therapy with clopidogrel given for up to one year after percutaneous coronary intervention results: from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial.

Authors:  Sean C Beinart; Paul Kolm; Emir Veledar; Zefeng Zhang; Elizabeth M Mahoney; Olivier Bouin; Sylvie Gabriel; Joseph Jackson; Roland Chen; Jaime Caro; Steven Steinhubl; Eric Topol; William S Weintraub
Journal:  J Am Coll Cardiol       Date:  2005-09-06       Impact factor: 24.094

5.  Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial.

Authors:  F Van De Werf; J Adgey; D Ardissino; P W Armstrong; P Aylward; G Barbash; A Betriu; A S Binbrek; R Califf; R Diaz; R Fanebust; K Fox; C Granger; J Heikkilä; S Husted; P Jansky; A Langer; E Lupi; A Maseri; J Meyer; J Mlczoch; D Mocceti; D Myburgh; A Oto; E Paolasso; K Pehrsson; R Seabra-Gomes; L Soares-Piegas; D Sùgrue; M Tendera; E Topol; P Toutouzas; A Vahanian; F Verheugt; L Wallentin; H White
Journal:  Lancet       Date:  1999-08-28       Impact factor: 79.321

6.  Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI).

Authors: 
Journal:  Lancet       Date:  1986-02-22       Impact factor: 79.321

7.  Routine invasive strategy within 24 hours of thrombolysis versus ischaemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): a randomised controlled trial.

Authors:  Francisco Fernandez-Avilés; Joaquín J Alonso; Alfonso Castro-Beiras; Nicolás Vázquez; Jesús Blanco; Juan Alonso-Briales; Juan López-Mesa; Felipe Fernández-Vazquez; Isabel Calvo; Luis Martínez-Elbal; José A San Román; Benigo Ramos
Journal:  Lancet       Date:  2004 Sep 18-24       Impact factor: 79.321

8.  Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial.

Authors:  Keith A A Fox; Shamir R Mehta; Ron Peters; Feng Zhao; Nasser Lakkis; Bernard J Gersh; Salim Yusuf
Journal:  Circulation       Date:  2004-08-16       Impact factor: 29.690

9.  Gender-related outcome following percutaneous coronary intervention for ST-elevation myocardial infarction: data from the Austrian acute PCI registry.

Authors:  Alois Suessenbacher; Jakob Doerler; Hannes Alber; Josef Aichinger; Johann Altenberger; Werner Benzer; Guenter Christ; Sebastian Globits; Kurt Huber; Ronald Karnik; Georg Norman; Peter Siostrzonek; Gerald Zenker; Otmar Pachinger; Franz Weidinger
Journal:  EuroIntervention       Date:  2008-08       Impact factor: 6.534

10.  In-hospital mortality and clinical course of 20,891 patients with suspected acute myocardial infarction randomised between alteplase and streptokinase with or without heparin. The International Study Group.

Authors: 
Journal:  Lancet       Date:  1990-07-14       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.